UGCG and breast cancer: For example, key regulatory enzymes in the ceramides and sphingolipid metabolism such as glucosylceramide synthase [26,107], acid ceramidase [108,109], and ceramide kinase [110,111] are overexpressed in mammary tumor tissue and/or breast cancer cell lines, suggesting a strong association between ceramides and their intermediates on tumor progression.